focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Now the misunderstanding has been cleared up, it conveys a very positive RNS. The SP should actually have gone up on this news but several panic sellers evidently mis-interpreted the wording and bailed out.
Hopefully a decent bounce tomorrow after the subsequent clarifications from the CEO have sunk in.
It's this one on share muppets -
TW Bearcast, Jim Mellon, SalvaRx and the lessons from the todger spray episode
In today's delayed podcast I look at the lessons for SalvaRx (SALV) from the Plethora (PLE) & regent pacific episode and ask what is happening at Regent as its shares continue to slide?
It's marked as "Premium content", if anyone has access?
The Company, with its third party manufacturer, has now achieved significant manufacturing scale up, with no detrimental impact upon the active properties of the SkinBiotix® technology.
In addition the material, which to date has been manufactured and supplied in a liquid form, has now been successfully freeze dried. The ability to freeze dry the material is an important steps towards commercialisation as it enables mass production, storage and transportation.
The SkinBiotix® technology has been shown to be stable and effective within the cream formulation for 24 hours. The human study, which is due to commence in September, is subject to the Company's ongoing work to confirm stability of the current formulation over an extended timeframe. The Company expects to provide an update on this in the coming weeks.
Too many have written this off now, yet it's a case of tweaking some parameters and rerunning the trial. It's likely to be no more than just a delay until a successful outcome. I agree there is still risk but the drug works, the delivery system needs refining and we also have Nuvec.
Typical AIM that any bumps in the road and there's a mass exit for the door. Happy to hold here. 10p is a great entry IMV. it's too early to call this. Patience needed (a rare commodity on AIM!).
Just noticed Doggo already tweeted an estimate for this. Even at low end of that range it's most impressive.
Interested to hear news of next investment, could we hear something in next week or so, with results out of the way now?
If Factom Inc are doing a $50m series b fund raise, then one can estimate that their MCap must be in the region of say $150m min to $500m max. This values our 3.7% holding at $5.5m to $18.5m, but not accounting for dilution so a bit less with that factored in.
Either way that's a pretty cool re-rate and NAV goes up yet again.
I believe the closed period ends when results are issued, which is likely to be around 6th July (was 7th July last year). Not seen the actual date confirmed though.
The 2 large trades at 08:12 are one bed & ISA transaction, both marked as sells. Looking at the rest of trades today, buys definitely outnumber sells by a strong margin, yet we're 5% down. This is clearly being manipulated for some reason, it's been walked down for some purpose? Curious to find out what's going on here!
Lorne Abony tweet this morning -
@LorneAbony
Working very closely with Yooya to pivot towards a Blockchain business model. Great opportunity for Yooya to monetize their enormous content. Possible Factom partnership ? #ffwd
3:11 AM - 3 Jul 2018
TW also said that David Evans had sold out completely back in Sep 2017 - so you can never know what to believe from him. Either way it will be most welcome if the seller is out allowing the SP to move north, it's been such a long wait after all!
Two new tweets from Lorne Abony today. One about Yooya and Blockchain. The other is Coed below-
Lorne Abony @LorneAbony
·
4h
Having #IMG as a shareholder and partner at #LEAPGAMING is a game changer. Great things to come #FastForward Innovations
Results for the Year ended 31 March 2018 are due on 6th July, or thereabouts. We can expect a decent increase in NAV from last FY's results eg the sale of APH will provide a good uplift. In fact the current SP could even show a discount to the revised NAV, we shall see.
We can also expect a progress update across the FFWD portfolio, as is the norm. Some news on Yooya is overdue for sure.
I am baffled as to why the SP has been dropped down to this level, volumes aren't high, but I also don't believe it will stay down here for long. Just my personal view and not a deliberate ramp!
It's not the value of the Factom coin that's significant here, this is all about the Factom Inc series B fundraise which must be due to complete shortly. The two are not directly linked (ie Factom coin and Factom Inc).
Once the fund raise has concluded then our (approx 3%) holding of Factom Inc will re-rate and all indications are that it should be a significant increase. As a LTH I certainly hope so.
I believe they have £6M - £7M left after this investment. Maybe they will do some more buyback after results are out to get the SP back up?
A key announcement from that latest Factom release - "The end objective is to produce a commercially viable product ready to enter the market." We've had some delays with NDA announcements, BUT this is going to be massive, in my opinion.
After results are out the BOD has the option to resume buyback. With the SP this low, they'd be daft not to? They did pledge to buyback 25% in a previous resolution which was passed at AGM.
Well the investors who were here for weed (NUU, Aphria) only have now departed. We should soon get back on an upward trajectory IMV. We are in a closed period in the lead up to annual results, expected early July. Closed period on AIM is 30 days I believe.
I agree with the views on here. It certainly tests one's patience when no news is released for ages and SP is in downtrend. Results for the Year ended 31 March 2018 should be out before long, results were released in early July last year. We can expect an update on progress across the portfolio then. I certainly hope so! When we're in a results period, the company isn't allowed to buy shares so this may have implications for buyback, possibly.
A realistic valuation isn't readily attainable given that most of the investee companies in the FFWD Portfolio are unlisted. It's only when a company does an IPO or fundraise that a realistic value can be determined. When Factom does it's Series B fundraise we will no doubt see a significant premium to the price we paid. Much of the stated "value" we see in reports etc is based on purchase price, whereas the true value today could be many times higher. Even taking that low-end figure of 12p, this is still a 57% increase on the figure quoted in last year's company results (7.6p NAV). That's not a bad rise in value and that's at the bottom end of the scale. In reality I would expect the real value, taking account of recent and upcoming developments (eg in LEAP, FACTOM, VEMO to name just 3), to be much higher than 16p across the PF. At today's SP, FFWD is very undervalued in my view.